147 related articles for article (PubMed ID: 26235789)
1. Foveal microanatomy documented by SD-OCT following treatment of advanced retinoblastoma.
Samara WA; Pointdujour-Lim R; Say EA; Shields CL
J AAPOS; 2015 Aug; 19(4):368-72. PubMed ID: 26235789
[TBL] [Abstract][Full Text] [Related]
2. Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment.
Shields CL; Materin MA; Shields JA
Arch Ophthalmol; 2005 Nov; 123(11):1610-2. PubMed ID: 16286630
[No Abstract] [Full Text] [Related]
3. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
4. Vision and visual potential for perifoveal retinoblastoma after optical coherence tomographic-guided sequential laser photocoagulation.
Soliman SE; VandenHoven C; Mackeen LD; Gallie BL
Br J Ophthalmol; 2019 Jun; 103(6):753-760. PubMed ID: 29976784
[TBL] [Abstract][Full Text] [Related]
5. Long-term visual outcome following chemoreduction for retinoblastoma.
Demirci H; Shields CL; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Nov; 123(11):1525-30. PubMed ID: 16286614
[TBL] [Abstract][Full Text] [Related]
6. Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography.
Wakabayashi T; Oshima Y; Fujimoto H; Murakami Y; Sakaguchi H; Kusaka S; Tano Y
Ophthalmology; 2009 Mar; 116(3):519-28. PubMed ID: 19147231
[TBL] [Abstract][Full Text] [Related]
7. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
[TBL] [Abstract][Full Text] [Related]
8. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
9. Visual outcome in macular retinoblastoma treated with primary chemotherapy.
Balasubramanya R; Pushker N; Bajaj MS; Rani A; Ghose S; Arya LS
Ophthalmologica; 2003; 217(6):417-21. PubMed ID: 14573975
[TBL] [Abstract][Full Text] [Related]
10. Correlation between spectral-domain optical coherence tomography findings and visual outcome after primary rhegmatogenous retinal detachment repair.
Gharbiya M; Grandinetti F; Scavella V; Cecere M; Esposito M; Segnalini A; Gabrieli CB
Retina; 2012 Jan; 32(1):43-53. PubMed ID: 21778929
[TBL] [Abstract][Full Text] [Related]
11. Uveitis masquerade syndromes: diffuse retinoblastoma in an older child.
All-Ericsson C; Economou MA; Landau I; Träisk F; Seregard S
Acta Ophthalmol Scand; 2007 Aug; 85(5):569-70. PubMed ID: 17655613
[No Abstract] [Full Text] [Related]
12. Resolution of iris neovascularization following chemoreduction of retinoblastoma.
Patel J; Turaka K; Shields CL
J Pediatr Ophthalmol Strabismus; 2010 Oct; 47 Online():e1-3. PubMed ID: 21162463
[TBL] [Abstract][Full Text] [Related]
13. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
14. Visual prognosis of retinoblastoma in the posterior pole treated with primary chemotherapy plus local treatments.
Kim JM; Kim JH; Kim SJ; Park KD; Shin HY; Ahn HS; Yu YS
Korean J Ophthalmol; 2010 Dec; 24(6):347-52. PubMed ID: 21165233
[TBL] [Abstract][Full Text] [Related]
15. What is the best treatment for retinoblastoma?
Harbour JW
Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
[No Abstract] [Full Text] [Related]
16. Alive with good vision: the ultimate goal in managing retinoblastoma.
Kivelä T
Clin Exp Ophthalmol; 2012; 40(7):655-6. PubMed ID: 23046171
[No Abstract] [Full Text] [Related]
17. Eye salvage in diffuse anterior retinoblastoma using systemic chemotherapy with periocular and intravitreal topotecan.
Rao R; Honavar SG; Mulay K; Reddy VAP
J AAPOS; 2018 Jun; 22(3):235-237.e2. PubMed ID: 29698780
[TBL] [Abstract][Full Text] [Related]
18. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
19. Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
Shields CL; Sun H; Manquez ME; Leahey A; Meadows AT; Shields JA
Arch Ophthalmol; 2006 Aug; 124(8):1196-7. PubMed ID: 16908826
[No Abstract] [Full Text] [Related]
20. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
